Study protocol of an open-label, single arm phase II trial investigating the efficacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with Oxaliplatin and 5-fluorouracil/Folinic acid followed by curative surgical resection in patients with hepatic Oligometastatic adenocarcinoma of the pancreas (HOLIPANC)

BACKGROUND: According to current guidelines, treatment of patients with hepatic oligometastasis in pancreatic cancer is not reflected and systemic chemotherapy is recommended in those patients. Retrospective data suggest beneficial outcomes in patients with hepatic oligometastasis, though prospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Gebauer, Florian, Damanakis, Alexander Ioannis, Popp, Felix, Quaas, Alexander, Kütting, Fabian, Lutz, Katrin, Held, Swantje, Deuß, Burkhard, Göser, Tobias, Waldschmidt, Dirk, Bruns, Christiane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600696/
https://www.ncbi.nlm.nih.gov/pubmed/34794396
http://dx.doi.org/10.1186/s12885-021-08966-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600696/
https://www.ncbi.nlm.nih.gov/pubmed/34794396
http://dx.doi.org/10.1186/s12885-021-08966-3

Ejemplares similares